Happy New Year to all, (albeit a little belated)! We enjoyed our break, and we're now recharged and ready for a fabulous year of translational cancer research.
We've got a new website in the works, alongside our fresh newsletter design. We're also busy behind the scenes, planning our upcoming Sydney Catalyst International Translational Cancer Research Symposium (SCITCRS) so keep an eye out for registrations opening soon. If you're keen for some symposium action in the short term, take a look out our Post-Graduate and Early Career Researcher Symposium and register via this very newsletter.
WHERE: Robert Lusby Auditorium, Concord medical School
WHEN: Friday 28th April, 2017
Be part of this inspiring event to:
Network and establish collaborations with Sydney Catalyst members from at least 30 member groups.
Learn about translational research across the full translational continuum from T1-T3.
Gain feedback and advice from leading Sydney Catalyst members and other students and early career researchers in a friendly atmosphere.
Our keynote speaker for the day is Barbara Fazekas De St Groth, Director, Ramaciotti Facility for Human Systems Biology and Professor, Discipline of Pathology, Sydney Medical School.
We've designed the day with collaboration and networking in mind, starting with a relaxed morning tea and plenty of time to meet other participants from within and outside your area of expertise.
The program, being developed by our multi-institutional working group, will include a keynote presentation, a range of abstract presentations by participants, along with a selection of 3 Minute Pet Project Presentations.
Call for abstracts: If you are interested in presenting a brief oral paper about your own research, please submit a short abstract (max. 200 words) with your registration form. Abstract submissions close Friday 17 March, 2017.
CINSW recently opened applications for 2017 Research Equipment Grants (REGs). Further information, application form and guidelines are available on the CINSW website. If you wish to apply for an REG as a Sydney Catalyst member and need our support, please contact us well before application close date of 9 March 2017 and we'll sort you out.
We are pleased to announce that we will soon open applications for the 2017 round of funding for Flagship program 2 - the Sydney Catalyst Pilot and Seed (P&S) Program. This essential component of our research strategy aims to support the development of new concepts and projects that will:
Lead to future larger programs of work (e.g. leverage funding from external sources, lead to immediate adoption of evidence in practice); and/or
Build capacity in translational cancer research (e.g. supporting early and mid-career researchers, support otherwise under-represented research areas and disciplines).
After winning the Vice Chancellor's Award for Excellence in the category of Outstanding Contribution to Research Excellence in 2016, the Sydney Catalyst team was given an opportunity to undertake a team building exercise as part of the prize.
We chose to scale new heights together, summiting the Harbour Bridge and marveling at the view of our beautiful city, before returning to ground level, shaky-legged, full of adrenalin, and ready to tackle a new year of translational cancer research together.
USYD CANCER CONSULTATION
The University is seeking feedback on how best to drive excellence, scale and impact of cancer research at the University of Sydney. They'd like your input to design new multidisciplinary university-wide initiatives focused on cancer, a make them a national and global priority.
All members of the university community are invited to provide input via:
Online submissions - Now open until 5pm, 6 March 2017
We love sharing the news when we spot Sydney Catalyst members out in the community, spreading the word of their research and clinical applications. Check out the articles below to see who's been in the news recently.
Breakthrough in Treating Asbestos Related Cancer
Sydney Catalyst member Dr Nico van Zandwijk, Director of the Asbestos Diseases Research Institute, spoke to Channel 9’s A Current Affair in December about this decade's most significant breakthrough in
asbestos related cancer treatment. Check out the Sydney Health Partners website to watch the story and hear from patients who have directly benefited from ADRI's groundbreaking research.
The SREI 2020 scheme supports cross-discipline and interdisciplinary proposals driving global research excellence. It encourages colleagues to push boundaries and be ambitious in their risk-taking towards research success.
EVENTS + OPPORTUNITIES
As always we have some exciting Sydney Catalyst events and industry opportunities coming up. Check out the highlights below and then head to our websitefor even more.